Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Frontiers in Pharmacology|October 4, 2018
Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting DatabaseÉmeline Courtois, Antoine Pariente, Francesco Salvo, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control studyAnne Bénard-Laribière, Emilie Hucteau, Stéphanie Debette, et al.
Fundamental & Clinical Pharmacology|February 23, 2026
SGLT-2 Inhibitors Use in Hospitalized Patients in France: A Cross-Sectional StudyMaxime Demourgues, Julien Bezin, Romain Griffier, et al.
Drug Safety|November 17, 2010
Case series in drug safety: a review to determine characteristics and qualityClaire Nour Abou Chakra, Antoine Pariente, Marion Pinet, et al.
Plos One|February 1, 2019
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real dataBernard C Silenou, Marta Avalos, Catherine Helmer, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiologyJulien Bezin, Mai Duong, Régis Lassalle, et al.
Diabetes, Obesity & Metabolism|January 30, 2024
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance databaseSibylle de Germay, Elodie Pambrun, Antoine Pariente, et al.
Drug Safety|November 30, 2017
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot StudyMickael Arnaud, Bernard Bégaud, Frantz Thiessard, et al.
Clinical Pharmacology and Therapeutics|September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life SettingJulien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2008
Prevalence of cholinesterase inhibitors in subjects with dementia in EuropeAntoine Pariente, Catherine Helmer, Yvon Merliere, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Frontiers in Pharmacology|October 4, 2018
Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting DatabaseÉmeline Courtois, Antoine Pariente, Francesco Salvo, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control studyAnne Bénard-Laribière, Emilie Hucteau, Stéphanie Debette, et al.
Fundamental & Clinical Pharmacology|February 23, 2026
SGLT-2 Inhibitors Use in Hospitalized Patients in France: A Cross-Sectional StudyMaxime Demourgues, Julien Bezin, Romain Griffier, et al.
Drug Safety|November 17, 2010
Case series in drug safety: a review to determine characteristics and qualityClaire Nour Abou Chakra, Antoine Pariente, Marion Pinet, et al.
Plos One|February 1, 2019
Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real dataBernard C Silenou, Marta Avalos, Catherine Helmer, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiologyJulien Bezin, Mai Duong, Régis Lassalle, et al.
Diabetes, Obesity & Metabolism|January 30, 2024
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance databaseSibylle de Germay, Elodie Pambrun, Antoine Pariente, et al.
Drug Safety|November 30, 2017
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot StudyMickael Arnaud, Bernard Bégaud, Frantz Thiessard, et al.
Clinical Pharmacology and Therapeutics|September 7, 2017
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life SettingJulien Bezin, Olaf H Klungel, Régis Lassalle, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2008
Prevalence of cholinesterase inhibitors in subjects with dementia in EuropeAntoine Pariente, Catherine Helmer, Yvon Merliere, et al.
Pageof 22